IPCIQ.US Intellipharmaceutics International Inc.

Healthcare Biotechnology USA Stocks
0.1500 USD
Close of Nov 15, 2026
0.1500 0.1500
Market cap
USD 4.96M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Nov 2022.

Is IPCIQ.US undervalued?

Graham number

The Graham number of Intellipharmaceutics International Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Intellipharmaceutics International Inc. fundamental analysis

No fundamental analysis for Intellipharmaceutics International Inc. yet.

Intellipharmaceutics International Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Foca…

Full company profile